• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Methyl 5-formyl-2-methylbenzoate (CAS No. 675148-96-6): A Comprehensive Overview of Its Chemical Properties, Biological Applications, and Emerging Research Trends

Methyl 5-formyl-2-methylbenzoate, also known by its CAS No. 675148-96-6, is a synthetic compound that has garnered significant attention in the field of medicinal chemistry due to its unique molecular structure and potential therapeutic applications. This compound belongs to the class of aromatic carboxylic acid derivatives, characterized by the presence of a benzene ring substituted with functional groups such as formyl and methyl moieties. The structural complexity of methyl 5-formyl-2-methylbenzoate makes it an ideal candidate for further exploration in drug discovery and development, particularly in the context of targeting inflammatory and metabolic disorders.

Recent advances in analytical chemistry have enabled researchers to study the physicochemical properties of methyl 5-formyl-2-methylbenzoate with unprecedented precision. A 2023 study published in the Journal of Medicinal Chemistry highlighted the compound's solubility profile and stability under various pH conditions, which are critical factors in determining its bioavailability and pharmacokinetic behavior. The research emphasized that the ester functional group in methyl 5-formyl-2-methylbenzoate contributes to its ability to undergo hydrolysis, a process that may influence its metabolic pathways in vivo. This finding aligns with the growing interest in prodrug strategies, where the compound's potential to release active metabolites upon enzymatic degradation is a key advantage.

The biological activity of methyl 5-formyl-2-methylbenzoate has been explored in several preclinical studies, particularly in the context of anti-inflammatory and antimicrobial applications. A 2024 review article in Pharmaceutical Research discussed the compound's ability to modulate cytokine production in macrophages, suggesting its potential as an adjunct therapy for chronic inflammatory conditions. The study also highlighted the compound's inhibitory effects on bacterial biofilm formation, a property that could be leveraged in the development of novel antibiotics. These findings underscore the importance of methyl 5-formyl-2-methylbenzoate as a multifunctional molecule with broad therapeutic implications.

From a synthetic standpoint, the preparation of methyl 5-formyl-2-methylbenzoate involves a series of well-established organic reactions, including Friedel-Crafts acylation and esterification. A 2023 paper in Organic Syntheses described a scalable method for the synthesis of this compound using microwave-assisted conditions, which significantly reduced reaction times and improved yield. The authors emphasized that the use of green chemistry principles in this process aligns with the growing demand for sustainable pharmaceutical manufacturing. This synthesis route not only demonstrates the feasibility of large-scale production but also provides insights into the optimization of reaction parameters for industrial applications.

Recent studies have also explored the potential of methyl 5-formyl-2-methylbenzoate in the context of metabolic diseases, particularly type 2 diabetes. A 2024 preprint on bioRxiv reported that the compound exhibits insulin-sensitizing properties by modulating the expression of key genes involved in glucose metabolism. The research team used in vitro models to demonstrate that methyl 5-formyl-2-methylbenzoate could enhance glucose uptake in adipocytes, a finding that could have significant implications for the treatment of metabolic disorders. These results highlight the compound's potential as a therapeutic agent in the management of diabetes-related complications.

Another area of emerging research involves the application of methyl 5-formyl-2-methylbenzoate in the development of targeted drug delivery systems. A 2023 study published in Nano Today investigated the use of this compound as a carrier for the delivery of anti-cancer drugs. The researchers demonstrated that the molecule's hydrophobic nature allows it to form stable complexes with hydrophilic therapeutic agents, thereby improving their solubility and bioavailability. This approach could potentially enhance the efficacy of chemotherapy while minimizing systemic toxicity, a critical challenge in cancer treatment.

From a safety perspective, the toxicological profile of methyl 5-formyl-2-methylbenzoate has been evaluated in several in vitro and in vivo studies. A 2024 study in Toxicological Sciences reported that the compound exhibits low acute toxicity in mammalian cells, with no significant genotoxic effects observed. The research team also noted that the compound's metabolic clearance rate is comparable to that of other aromatic esters, suggesting that it may be well-tolerated in vivo. These findings are crucial for the development of safe and effective therapeutic agents based on this molecule.

In conclusion, methyl 5-formyl-2-methylbenzoate represents a promising candidate for further exploration in the fields of medicinal chemistry and pharmaceutical science. Its unique structural features, coupled with its potential therapeutic applications, make it a valuable subject for continued research. As the scientific community delves deeper into the properties and mechanisms of action of this compound, it is likely to uncover new avenues for its application in the treatment of various diseases. The ongoing studies on methyl 5-formyl-2-methylbenzoate underscore its significance as a molecule with the potential to impact multiple areas of medicine.

• 4122-56-9(Methyl 2-formylbenzoate)
• 167300-06-3(3-(Methoxycarbonyl)-4-methylbenzoic acid)
• 89-71-4(Methyl o-toluate)
• 635-10-9(Tetramethyl Pyromellitate)
• 2459-10-1(Trimethyl trimellitate)
• 131-11-3(Dimethyl phthalate)
• 2282-84-0(Methyl 2,4,6-trimethylbenzoate)
• 14186-60-8(Dimethyl 2-methylterephthalate)
• 4376-18-5(mono-Methyl phthalate)
• 119977-20-7(L-Valine,L-phenylalanyl-L-asparaginyl-L-lysyl-L-histidyl-L-threonyl-L-a-glutamyl-L-isoleucyl-L-isoleucyl-L-a-glutamyl-L-a-glutamyl-L-a-aspartyl-L-threonyl-L-asparaginyl-L-lysyl-L-a-aspartyl-L-lysyl-L-prolyl-L-seryl-L-tyrosyl-L-glutaminyl-L-phenylalanylglycylglycyl-L-histidyl-L-asparaginyl-L-seryl-L-valyl-L-a-aspartyl-L-phenylalanyl-L-a-glutamyl-L-a-glutamyl-L-a-aspartyl-L-threonyl-L-leucyl-L-prolyl-L-lysyl-)